Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sukumar Nagendran Insider Profile
11 Followers
Sukumar Nagendran, Sr. VP & Chief Medical Officer at AveXis Inc, holds 897.84K shares in Taysha Gene Therapies (Ticker: TSHA), holds 34.26K shares in Solid Biosciences (Ticker: SLDB), holds 0.00 shares in AveXis Inc (Ticker: AVXS).
Sukumar Nagendran AveXis Inc (AVXS)Sr. VP & Chief Medical Officer
AveXis Inc (AVXS)
Sr. VP & Chief Medical Officer
Ranked #20,059 out of 99,797 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+128.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Sukumar Nagendran holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 18, 2023 - May 18, 2024
Return:+341.40%
The most profitable trade made by Sukumar Nagendran
Sukumar Nagendran's Trading History
AveXis Inc
May 15, 2018
―
Uninformative Sell
―
$0.00
Solid Biosciences
Jul 29, 2019
Director
Uninformative Buy
150.00K
$142.51K
Taysha Gene Therapies
Jan 04, 2024
President and Head of R&D, Director
Uninformative Buy
―
$1.66M
List of latest transactions for each holding click on a transaction to see Sukumar Nagendran's performance on stock
You May Also Like
Sukumar Nagendran insider profile FAQ
What is the percentage of profitable transactions made by Sukumar Nagendran?
The percentage of profitable transactions made by Sukumar Nagendran is 50%.
What is the average return per transaction made by Sukumar Nagendran?
The average return per transaction made by Sukumar Nagendran is 128.50%.
What stocks does Sukumar Nagendran hold?
Sukumar Nagendran holds: AVXS, SLDB, TSHA stocks.
What was Sukumar Nagendran’s latest transaction?
Sukumar Nagendran latest transaction was an Uninformative Buy of ―.
What was Sukumar Nagendran's most profitable transaction?
Sukumar Nagendran’s most profitable transaction was an Informative Buy of TSHA stock on May 18, 2023. The return on the trade was 341.40%.
What is Sukumar Nagendran's role in AveXis Inc?
Sukumar Nagendran's role in AveXis Inc is Sr. VP & Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.